Concepedia

Alain P. Algazi

AP

87

Publications

21.9K

Citations

52

H-Index

1991

Active since

Affiliations

University of California, San Francisco(Current)

University of California, Los Angeles

Memorial Sloan Kettering Cancer Center

The University of Texas MD Anderson Cancer Center

Moffitt Cancer Center

Alain P. Algazi is an author at University of California, San Francisco specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

1991–2024

87

Publications

87

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

Omid Hamid, Caroline Robert, Adil Daud et al. · New England Journal of Medicine · 2013 · 3.4K citations · Full text

Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

Keith T. Flaherty, J. Infante, Adil Daud et al. · New England Journal of Medicine · 2012 · 2.8K citations · Full text

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau et al. · The Lancet · 2018 · 1.6K citations · Full text

, , +5

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

Hussein A. Tawbi, Peter Forsyth, Alain P. Algazi et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma

Antoni Ribas, Omid Hamid, Adil Daud et al. · JAMA · 2016 · 1K citations · Full text

Rows per page

1–5 of 87